Boston Baskin Cancer Group D/B/A/ UTCI — Memphis, Tennessee

Boston Baskin Cancer Group D/B/A/ UTCI is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Boston Baskin Cancer Group D/B/A/ UTCI has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer.

Sponsors: Agennix.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Baskin Cancer Group D/B/A/ UTCI?

Boston Baskin Cancer Group D/B/A/ UTCI has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Baskin Cancer Group D/B/A/ UTCI conducted?

Boston Baskin Cancer Group D/B/A/ UTCI has 1 clinical trials on record. Their work covers Prostate Cancer.

Is Boston Baskin Cancer Group D/B/A/ UTCI accredited by Crixeo Health?

Boston Baskin Cancer Group D/B/A/ UTCI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Baskin Cancer Group D/B/A/ UTCI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.